This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Exploring the role of PARG in DNA repair and cancer
Charting the cellular spacial landscape in rare ovarian cancer
Identifying biomarkers of immunotherapy response in ovarian clear cell carcinoma
Establishing a national registry of clear cell and mucinous ovarian cancers
Exploring a new therapeutic approach for rare ovarian cancers
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
Optimizing an off-the shelf ovarian cancer RNA vaccine
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
Developing new treatments for clear cell ovarian cancer
